Q3 2025 · 13F-HR
Bratton Capital Management, L.P.holdings as filed
Filed 2025-11-14 · accession 0001315863-25-000804
$54.8M
Reported value
1
Positions
2025-09-30
Period end
The Brief · Bratton Capital Management, L.P. · Q3 2025
AI · grounded in 13F
Bratton Capital Management, L.P. established a new position in Aquestive Therapeutics Inc AQST valued at $54.8M. This single holding represents the entirety of the fund's $54.8M total assets under management. The fund added no other positions and recorded no sells during the period.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $54.8M | 100.0% | 9,810,958 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.